 Carolina Ortiz-Lopez
Concepts (98)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Contrast Media | 4 | 2016 | 488 | 0.860 |
Why?
| | Fatty Liver | 5 | 2014 | 251 | 0.610 |
Why?
| | Lower Extremity | 3 | 2016 | 438 | 0.490 |
Why?
| | Radiography, Interventional | 2 | 2016 | 130 | 0.480 |
Why?
| | Triiodobenzoic Acids | 1 | 2014 | 6 | 0.440 |
Why?
| | Non-alcoholic Fatty Liver Disease | 8 | 2016 | 266 | 0.430 |
Why?
| | Peripheral Arterial Disease | 3 | 2016 | 503 | 0.410 |
Why?
| | Prediabetic State | 2 | 2016 | 245 | 0.380 |
Why?
| | Diabetic Angiopathies | 1 | 2014 | 263 | 0.370 |
Why?
| | Coronary Angiography | 1 | 2014 | 323 | 0.360 |
Why?
| | Ischemia | 1 | 2014 | 421 | 0.340 |
Why?
| | Pain | 1 | 2014 | 782 | 0.290 |
Why?
| | Vascular Access Devices | 2 | 2015 | 30 | 0.220 |
Why?
| | Catheterization, Peripheral | 2 | 2015 | 119 | 0.200 |
Why?
| | Overweight | 3 | 2015 | 609 | 0.200 |
Why?
| | Point-of-Care Systems | 1 | 2025 | 187 | 0.200 |
Why?
| | Diabetes Mellitus | 1 | 2012 | 1098 | 0.190 |
Why?
| | Obesity | 5 | 2016 | 3082 | 0.190 |
Why?
| | Internal Medicine | 1 | 2025 | 280 | 0.190 |
Why?
| | Endovascular Procedures | 2 | 2016 | 384 | 0.160 |
Why?
| | Curriculum | 1 | 2025 | 1060 | 0.140 |
Why?
| | Diabetes Mellitus, Type 2 | 4 | 2016 | 2584 | 0.130 |
Why?
| | Hyperinsulinism | 2 | 2016 | 113 | 0.120 |
Why?
| | Insulin Resistance | 6 | 2016 | 1241 | 0.120 |
Why?
| | Angiography, Digital Subtraction | 1 | 2015 | 48 | 0.110 |
Why?
| | Thiazolidinediones | 1 | 2016 | 139 | 0.110 |
Why?
| | Angiography | 1 | 2016 | 208 | 0.110 |
Why?
| | Internship and Residency | 1 | 2025 | 1257 | 0.110 |
Why?
| | Popliteal Artery | 1 | 2015 | 62 | 0.110 |
Why?
| | Arterial Occlusive Diseases | 1 | 2015 | 90 | 0.100 |
Why?
| | Severity of Illness Index | 4 | 2015 | 2925 | 0.100 |
Why?
| | Liver | 4 | 2016 | 1888 | 0.100 |
Why?
| | Keratin-18 | 1 | 2013 | 12 | 0.100 |
Why?
| | Radiography | 1 | 2014 | 845 | 0.090 |
Why?
| | Hyperglycemia | 2 | 2012 | 375 | 0.080 |
Why?
| | Liver Cirrhosis | 1 | 2013 | 288 | 0.080 |
Why?
| | Case-Control Studies | 3 | 2014 | 3608 | 0.080 |
Why?
| | Diabetes Complications | 1 | 2012 | 223 | 0.080 |
Why?
| | Metabolome | 1 | 2012 | 384 | 0.070 |
Why?
| | Middle Aged | 10 | 2016 | 35928 | 0.070 |
Why?
| | Acute Kidney Injury | 1 | 2016 | 866 | 0.070 |
Why?
| | Adipose Tissue | 1 | 2012 | 653 | 0.070 |
Why?
| | Male | 11 | 2016 | 72406 | 0.060 |
Why?
| | Ultrasonography | 2 | 2025 | 770 | 0.060 |
Why?
| | Humans | 14 | 2025 | 144957 | 0.060 |
Why?
| | Hypoglycemic Agents | 1 | 2016 | 1389 | 0.060 |
Why?
| | Female | 11 | 2016 | 78376 | 0.060 |
Why?
| | Prevalence | 1 | 2012 | 2836 | 0.050 |
Why?
| | Triglycerides | 2 | 2016 | 521 | 0.050 |
Why?
| | Delphi Technique | 1 | 2025 | 331 | 0.050 |
Why?
| | Glucose Clamp Technique | 2 | 2016 | 199 | 0.050 |
Why?
| | Consensus | 1 | 2025 | 489 | 0.050 |
Why?
| | Predictive Value of Tests | 2 | 2015 | 2118 | 0.040 |
Why?
| | Incidence | 2 | 2016 | 2883 | 0.030 |
Why?
| | Clinical Competence | 1 | 2025 | 1244 | 0.030 |
Why?
| | Transaminases | 1 | 2016 | 22 | 0.030 |
Why?
| | Diet, Reducing | 1 | 2016 | 91 | 0.030 |
Why?
| | Punctures | 1 | 2015 | 40 | 0.030 |
Why?
| | Body Mass Index | 2 | 2016 | 2438 | 0.030 |
Why?
| | Cholesterol, HDL | 1 | 2016 | 200 | 0.030 |
Why?
| | Models, Anatomic | 1 | 2015 | 84 | 0.030 |
Why?
| | Adult | 3 | 2016 | 40506 | 0.030 |
Why?
| | Glucose Tolerance Test | 1 | 2016 | 361 | 0.030 |
Why?
| | Vascular Patency | 1 | 2015 | 121 | 0.030 |
Why?
| | Models, Cardiovascular | 1 | 2015 | 195 | 0.030 |
Why?
| | Drug Administration Schedule | 1 | 2016 | 783 | 0.030 |
Why?
| | Femoral Artery | 1 | 2015 | 190 | 0.030 |
Why?
| | Dyslipidemias | 1 | 2016 | 182 | 0.030 |
Why?
| | Cholesterol, LDL | 1 | 2016 | 358 | 0.030 |
Why?
| | Insulin | 2 | 2016 | 2507 | 0.030 |
Why?
| | Texas | 1 | 2015 | 278 | 0.030 |
Why?
| | Equipment Design | 1 | 2015 | 530 | 0.030 |
Why?
| | Comparative Effectiveness Research | 1 | 2015 | 170 | 0.020 |
Why?
| | Biomarkers | 2 | 2016 | 4275 | 0.020 |
Why?
| | ROC Curve | 1 | 2015 | 615 | 0.020 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2015 | 631 | 0.020 |
Why?
| | Weight Gain | 1 | 2016 | 559 | 0.020 |
Why?
| | Radioimmunoassay | 1 | 2012 | 165 | 0.020 |
Why?
| | Biopsy, Needle | 1 | 2012 | 183 | 0.020 |
Why?
| | Biopsy | 1 | 2015 | 1077 | 0.020 |
Why?
| | Animals | 1 | 2014 | 38109 | 0.020 |
Why?
| | Double-Blind Method | 1 | 2016 | 2029 | 0.020 |
Why?
| | Risk Factors | 2 | 2016 | 10792 | 0.020 |
Why?
| | Age Distribution | 1 | 2012 | 403 | 0.020 |
Why?
| | Sex Distribution | 1 | 2012 | 386 | 0.020 |
Why?
| | Adiposity | 1 | 2016 | 543 | 0.020 |
Why?
| | Reference Values | 1 | 2012 | 798 | 0.020 |
Why?
| | Treatment Outcome | 2 | 2016 | 11695 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 2014 | 1495 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2012 | 1311 | 0.020 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2015 | 653 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2012 | 1718 | 0.020 |
Why?
| | United States | 1 | 2025 | 15988 | 0.020 |
Why?
| | Risk Assessment | 1 | 2016 | 3676 | 0.010 |
Why?
| | Registries | 1 | 2015 | 2385 | 0.010 |
Why?
| | Cohort Studies | 1 | 2016 | 5965 | 0.010 |
Why?
| | Aged | 2 | 2015 | 25947 | 0.010 |
Why?
| | Prognosis | 1 | 2012 | 4293 | 0.010 |
Why?
|
|
Ortiz-Lopez's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|